KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Long-Term Debt Repayments (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Long-Term Debt Repayments for 14 consecutive years, with $2.5 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Long-Term Debt Repayments fell 33.9% year-over-year to $2.5 billion, compared with a TTM value of $3.6 billion through Dec 2024, down 37.62%, and an annual FY2025 reading of $2.4 billion, down 33.13% over the prior year.
  • Long-Term Debt Repayments was $2.5 billion for Q4 2024 at Thermo Fisher Scientific, up from $1.1 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $8.9 billion in Q4 2021 and bottomed at -$2.0 million in Q4 2020.
  • Average Long-Term Debt Repayments over 5 years is $1.9 billion, with a median of $1.0 billion recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments tumbled 100.04% in 2020, then surged 446850.0% in 2021.
  • Year by year, Long-Term Debt Repayments stood at -$2.0 million in 2020, then soared by 446850.0% to $8.9 billion in 2021, then crashed by 95.8% to $375.0 million in 2022, then surged by 908.53% to $3.8 billion in 2023, then crashed by 33.9% to $2.5 billion in 2024.
  • Business Quant data shows Long-Term Debt Repayments for TMO at $2.5 billion in Q4 2024, $1.1 billion in Q3 2024, and $3.8 billion in Q4 2023.